Genetic Variation in lncRNA HOTSCRAMBL Modulates Hematopoietic Stem Cells
Recent research published in the journal Cell reveals a significant discovery regarding the genetic regulation of human hematopoietic stem cells. Scientists have identified an inherited genetic variant within a homeotic long noncoding RNA (lncRNA) named HOTSCRAMBL that offers protection against blood cancers. This specific variant functions by altering the splicing of HOXA9, a critical gene involved in blood cell development. By modifying this splicing process, the variant fine-tunes the self-renewal capabilities of hematopoietic stem cells, ensuring a balanced production of blood cells. Crucially, this mechanism acts as a constraint on HOXA-driven blood cancers, thereby reducing the risk of malignant transformation. The study highlights the complex role of noncoding RNAs in genetic regulation and suggests that natural genetic variations can serve protective functions against serious diseases. This finding provides new insights into the molecular mechanisms underlying leukemia and other blood disorders, potentially opening avenues for novel therapeutic strategies that mimic this protective effect to prevent or treat hematologic malignancies.
Wire timeline
Genetic Variation in lncRNA HOTSCRAMBL Modulates Hematopoietic Stem Cells
Recent research published in the journal Cell reveals a significant discovery regarding the genetic regulation of human hematopoietic stem cells. Scientists have identified an inherited genetic variant within a homeotic long noncoding RNA (lncRNA) named HOTSCRAMBL that offers protection against blood cancers. This specific variant functions by altering the splicing of HOXA9, a critical gene involved in blood cell development. By modifying this splicing process, the variant fine-tunes the self-renewal capabilities of hematopoietic stem cells, ensuring a balanced production of blood cells. Crucially, this mechanism acts as a constraint on HOXA-driven blood cancers, thereby reducing the risk of malignant transformation. The study highlights the complex role of noncoding RNAs in genetic regulation and suggests that natural genetic variations can serve protective functions against serious diseases. This finding provides new insights into the molecular mechanisms underlying leukemia and other blood disorders, potentially opening avenues for novel therapeutic strategies that mimic this protective effect to prevent or treat hematologic malignancies.
Cell